SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-182428
Filing Date
2013-04-29
Accepted
2013-04-29 17:09:18
Documents
11
Period of Report
2013-06-28
Effectiveness Date
2013-04-29

Document Format Files

Seq Description Document Type Size
1 DEF14A d524974ddef14a.htm DEF 14A 352223
2 GRAPHIC g524974g01c85.jpg GRAPHIC 9088
3 GRAPHIC g524974g52k26.jpg GRAPHIC 7343
4 GRAPHIC g524974g68m57.jpg GRAPHIC 7333
5 GRAPHIC g524974pc_001anew.jpg GRAPHIC 7056
6 GRAPHIC g524974pc_001bnew.jpg GRAPHIC 22063
7 GRAPHIC g524974pc_001cnew.jpg GRAPHIC 33554
8 GRAPHIC g524974pc_001d.jpg GRAPHIC 1266
9 GRAPHIC g524974pc_001e.jpg GRAPHIC 1386
10 GRAPHIC g524974pc_001f.jpg GRAPHIC 15406
11 GRAPHIC g524974pc_001gnew.jpg GRAPHIC 34261
  Complete submission text file 0001193125-13-182428.txt   546263
Mailing Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034
Business Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33958 | Film No.: 13792621
SIC: 2834 Pharmaceutical Preparations